Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 235

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 235
---
 consummated prior to the Extended Date. APx’s ability to consummate the Business Combination is dependent on a variety of factors, many of which are beyond APx’s control. Even if the Business Combination is approved by its shareholders, it is possible that redemptions will leave APx with insufficient cash to consummate the Business Combination on commercially acceptable terms, or at all. The fact that APx had and will have separate redemption periods in connection with the Extensions (as defined below) and the business combination vote could exacerbate these risks. Other than in connection with a redemption offer, Public Shareholders may be unable to recover their investment except through sales of Public Shares on the open market. The price of Public Shares may be volatile, and there can be no assurance that Public Shareholders will be able to dispose of Public Shares at favorable prices, or at all. BofA, the lead underwriter in the IPO, was previously compensated for underwriting services in connection with the IPO and was to be compensated further, on a deferred basis, for already -rendered underwriting services in connection with the IPO, yet BofA, without any consideration from APx or the Company, waived its entitlement to such compensation solely with respect to the Business Combination and disclaimed any responsibility for this proxy statement / prospectus, but BofA remains entitled to customary indemnification and contribution obligations of APx in connection with the IPO. BofA Securities, Inc, the underwriter in the IPO, was previously compensated in the aggregate amount of $3,450,000 for underwriting services in connection with the IPO and was to be compensated further in the aggregate amount of $6,037,500, on a deferred basis, for already -renderedunderwriting services in connection with the IPO, in connection with the closing of APx’s initial business combination. BofA did not identify any of the Potential Targets or participate in the due diligence regarding the Company. BofA has had no involvement in the proposed Business Combination and did not assist in (i) identifying or procuring the Company as a target business, (ii) developing any financial models or other evaluation materials relating to the Company or the Business Combination, (iii) marketing the Business Combination, (iv) preparing or reviewing this proxy statement/prospectus or any of the disclosure contained herein or (v) any other role in the Business Combination. Representatives of APx initiated discussions with representatives from BofA to discuss BofA’s deferred underwriting compensation given the lack of